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Abstract
The stress response is essential for survival, but it can be detrimental when persistently
activated during chronic stress. Therefore, the magnitude of the stress response must be
finely-tuned in order to be adaptive. Indeed, an animal’s stress response system normally
undergoes habituation that decreases responses to a repeated, familiar stressor. Importantly,
the same animal still responds normally, or even becomes sensitized, to an unfamiliar (novel)
stressor. This indicates that chronic stress simultaneously induces two opposing types of
plasticity, one that underlies habituated responses and another that drives sensitized
responses. The activation of the hypothalamic-pituitary-adrenal (HPA) axis — a hallmark of
the stress response — relies on the release of corticotropin releasing hormone (CRH) from
neuroendocrine neurons in the paraventricular nucleus of the hypothalamus (PVN). Our
recent study found that, in a mouse model of habituation to a repeated stressor, the intrinsic
excitability of CRH neurons decreases (representing a potential mechanism for habituation to
a familiar stressor). In this thesis, we investigated a potential mechanism that enables a
sensitized response to an unfamiliar stressor in the same habituation model. Considering that
afferent glutamatergic synapses are the major excitatory inputs onto CRH neurons, we
hypothesized that potentiation of these excitatory synapses represents a neural correlate for
sensitized responses to an unfamiliar stressor. By using patch clamp electrophysiology, we
studied glutamatergic synaptic transmission onto CRH neurons in ex vivo brain slices. In
support of our hypothesis, we found that habituation to repeated stress potentiated glutamate
synapses onto CRH neurons. More specifically, this potentiation manifested as a sensitization
to cAMP signaling that facilitated the release of glutamate. Furthermore, we revealed that
cAMP-induced facilitation of glutamate release was dependent on presynaptic
hyperpolarization-activated cyclic-nucleotide-gated (HCN) channels. This result identifies a
possible mechanism that supports stress sensitization of the HPA axis and suggests a novel
role for HCN channels in the PVN.

Keywords: stress, sensitization, HPA axis, paraventricular nucleus of the hypothalamus,
corticotropin releasing hormone, hyperpolarization-activated cyclic nucleotide-gated
channels
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Chapter 1

1

Introduction

1.1 The Stress Response
The stress response is an essential survival mechanism that evolved to enhance an
organism’s ability to respond when a threat is perceived. This emergency response —
also referred to as the fight-or-flight response — involves the coordination of the nervous
and endocrine systems to prime the animal to fight off an impending challenge or escape
to safety. One important aspect of the stress response is the activation of the
hypothalamic-pituitary-adrenal (HPA) axis and the subsequent release of stress hormones
(glucocorticoids, GCs) into the bloodstream that have widespread physiological and
psychological effects on the animal. While vital in life threatening situations, long-term
activation of the stress response can be detrimental. For example, long-term elevated
glucocorticoid levels have been implicated in immune system dysfunction, heart disease,
diabetes, and psychological conditions such as depression and post-traumatic stress
disorder (PTSD) (Lupien, McEwen, Gunnar, & Heim, 2009; McEwen, 2000).
Fortunately, animals have an innate ability to fine-tune the magnitude of the response in
accordance with the learned significance of a given stressor. Indeed, stress-induced
activation of the HPA axis becomes less and less pronounced when an animal is
repeatedly challenged by a predictable stressor (i.e., stress habituation). Importantly, the
same animal still maintains its ability to respond normally, or even becomes sensitized, to
a novel stressor. This points to complex forms of plasticity that allow the HPA axis to
respond with opposing outputs (sensitization and habituation) depending on the stressor.
These two forms of plasticity evolved to allow an animal to escape from the negative
consequences of glucocorticoid actions when confronted with a non-threatening stressor,
but to also maintain a response to unfamiliar (thus threatening) stressors that require
glucocorticoids to support a full-blown stress response.
It is important to emphasize that a sensitized stress response can be maladaptive and has
been implicated in human psychopathologies, such as major depressive disorder, bipolar
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disorder, anxiety, PTSD and psychosis (Harkness, Hayden, & Lopez-duran, 2015). For
this reason, understanding the underlying neural mechanisms for this stress-induced
plasticity is fundamental to advance our understanding of these diseases. Despite its
importance, the neural mechanisms that support sensitization have not been identified.
This project investigates the neural mechanisms that allow the stress response to
overcome habituation and respond to novel or unfamiliar stressors. Here, we use a mouse
model of chronic stress, repeated restraint stress (RRS), that has been shown to lead to
HPA axis habituation to a repeated stressor (restraint) while responding normally (or in a
sensitized manner) to a novel stressor.

1.2 The HPA Axis
The HPA axis is the neuroendocrine arm of the stress response that ultimately leads to the
release of stress hormones to mobilize stored energy and prepare the body to respond to a
stressor. It begins with neuroendocrine neurons in the paraventricular nucleus of the
hypothalamus (PVN), which release corticotropin releasing hormone (CRH) into the
hypophyseal portal circulation. CRH (in addition to other co-released secretagogues)
stimulates the anterior pituitary to release adrenocorticotrophic hormone (ACTH) into the
general circulation (Vale & River, 1977), which in turn, travels to the adrenal cortex and
initiates the systemic release of glucocorticoids (GCs; Fig. 1.1).
GCs have widespread physiological effects throughout the body. GCs (primarily cortisol
in humans and corticosterone in animals) help the body to cope with a stressor by downregulating energy-demanding processes, such as growth, immune function and
reproduction and divert energy towards metabolism to increase available glucose in the
blood. In addition to these peripheral effects, GC receptors are widely expressed in the
brain and act as a negative feedback at various locations along the stress pathway (e.g.,
PVN, hippocampus, prefrontal cortex), as well as mediate the cognitive and emotional
changes associated with stress. Importantly, GCs play a role in mediating synaptic
plasticity along stress regulatory neural circuits that allows for modification of future
responses to stress (Sapolsky, Romero, & Munck, 2000). Although these changes are
adaptive in the short-term, it is well known that chronic GC exposure can be detrimental
(McEwen, 2000). For this reason, there must be mechanisms to control the plasticity of
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the HPA axis and maintain the delicate balance between adaptive and detrimental stress
responses.
Due to the widespread actions of GCs, the HPA axis plays a role in regulating digestion,
immune system function, sexuality, mood, and energy storage. Further, the HPA axis is
under circadian control and can also be activated by non-traditional stressors, such as
food intake (Dallman et al., 1987). However, for the purposes of this discussion, I will
focus on HPA activity in response to stress.
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Figure 1.1 The HPA axis
Schematic diagram showing the HPA axis hormonal cascade. Neuroendocrine neurons in
the PVN secrete CRH into the hypophyseal portal circulation. CRH travels to the anterior
pituitary and stimulates the secretion of ACTH into the bloodstream. ACTH acts on the
adrenal cortex to stimulate secretion of GCs, which act through negative feedback
mechanisms on the pituitary, hypothalamus and upstream brain targets to limit further
HPA axis activation.
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1.3 The PVN
1.3.1

Cell Types

Neuroendocrine CRH neurons, the apex of the HPA axis, cluster in the PVN. However,
the PVN is a heterogenous structure with a complex organization of multiple different
cell types besides neuroendocrine CRH neurons. These are organized into three main
categories: 1) magnocellular neuroendocrine neurons, which secrete oxytocin and
vasopressin to the posterior pituitary; 2) parvocellular neuroendocrine neurons, that
release CRH and other hormones to the anterior pituitary by way of the median eminence
and hypophyseal portal circulation; and 3) parvocellular preautonomic neurons, that
project to the brainstem and spinal cord to regulate the autonomic response to stress
(Tasker & Dudek, 1991).
These cell types can be distinguished based on the hormones they secrete but also by
their electrophysiological properties. Differential ion channel expression between the
three categories allows for identification by unique electrophysiological “fingerprints”
(Fig. 1.2) in an ex vivo whole-cell patch clamp configuration (Luther et al., 2002; Luther
& Tasker, 2000). Magnocellular neurons are characterized by a transient outward
rectification upon depolarization from a hyperpolarized membrane potential (Fig. 1.2 B).
This is mediated by voltage-gated A-type potassium (K+) channels (IA) and causes a
delay to the onset of action potential firing (i.e., delay to first spike) (Tasker & Dudek,
1991). Parvocellular preautonomic neurons exhibit a characteristic low-threshold spike
upon depolarization from a hyperpolarized membrane potential (Fig. 1.2 D). This is due
to the opening of low threshold-activated T-type Calcium (Ca2+) channels (IT).
Parvocellular neuroendocrine neurons, which include CRH secreting cells, can be
distinguished by their lack of outward rectification and a minimal low-threshold T-type
Ca2+ component (Fig. 1.2 C) (Tasker & Dudek, 1991). Instead, depolarization of these
neurons produces tonic firing. As these parvocellular CRH neurons form the apex of the
HPA axis, they will be our focus of discussion in this study. It is important to note that
parvocellular neuroendocrine neurons in the PVN can secrete other peptide hormones in
addition to CRH, including: vasopressin, somatostatin, thyrotropin-releasing hormone,
enkephalin, and vasoactive inhibitory peptide (Simmons & Swanson, 2009). Small
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numbers of parvocellular neurons also synthesize and release growth-releasing hormone
and dopamine. Recent advances in genetic mouse models allow for the precise
identification of CRH-secreting parvocellular neurons, such as the CRH-reporter mouse
line characterized by Wamsteeker Cusulin and colleagues (2013).
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Figure 1.2 Electrophysiological fingerprints of cell types in the PVN
(A) Current clamp protocol used by Luther and Tasker (2000) to differentiate between
the three subtypes of neurons in the PVN. (B) Firing pattern of magnocellular PVN
neurons, showing characteristic outward rectification (black arrow) upon depolarization
due to A-type K+ channels (IA). (B) Parvocellular neurosecretory neurons (including
CRH neurons) exhibit a lack of outward rectification (black arrow) and a minimal low
threshold T-type Ca2+ component. (C) Parvocellular preautonomic neurons exhibit a low
threshold-activated T-type Ca2+ channel component (IT; black arrow) following
depolarization from a hyperpolarized membrane potential.
Modified from “Voltage-gated currents distinguish parvocellular from magnocellular
neurones in the rat hypothalamic paraventricular nucleus,” by J. A. Luther & J. G.
Tasker. 2000. The Journal of Physiology. 523(1): 193–209. Copyright (2000) The
Journal of Physiology. Reprinted with permission.
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1.3.2
1.3.2.1

Afferent Inputs to the PVN
Overview

The HPA axis can be activated by a wide variety of stress signals, including: visual,
auditory, somatosensory and olfactory cues of a predator; somatosensory and humoral
cues indicating pain, injury and inflammation; and psychological or emotional cues in
anticipation of stress. To accommodate the numerous types of information capable of
activating the HPA axis, the PVN is innervated by a wide variety of brain areas (Fig. 1.3).
These afferent projections converge on CRH neurons and control their activation through
different types of neurotransmitters and neuromodulators. It has been proposed that these
different inputs transmit signals for distinct types of stress. Specifically, Herman and
colleagues (2003), suggested that “real” stress and “perceived” stress are coded by
distinct circuits. Here, “real” stress is defined as a physiological challenge or physical
damage to the body (e.g., injury, pain, inflammation, loss of blood). This differs from
“predicted” or “perceived” stress, which are stress responses mounted in anticipation of,
rather than in reaction to, stimuli that signal threat to homeostasis. Accordingly, the
authors propose that “real” stress involves direct innervation by brainstem and
hypothalamic areas, whereas “perceived” stress has more involvement of limbic and
forebrain afferents by way of relay sites such as the bed nucleus of the stria terminalis
(BNST) (Herman et al., 2003). Importantly the precise roles of these afferents remain
elusive as there is much overlap and intermixing within the PVN, making it technically
difficult to study the physiological roles of afferents in isolation. In this section, we
review the key inputs to parvocellular, putative neuroendocrine CRH neurons in the
PVN.
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Figure 1.3 Major inputs to the PVN
Schematic diagram of the major inputs to the PVN. Abbreviations: AHA, anterior
hypothalamus; ARC, arcuate nucleus; BLA, basolateral amygdala; BNST, bed nucleus of
the stria terminalis; CeA, central amygdala; DMH, dorsomedial hypothalamus; Hc,
hippocampus; LC, locus coeruleus; MeA, medial amygdala; MnPO, medial preoptic
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nucleus; NTS, nucleus tractus solitarius; PBN, parabrachial nucleus; PVT,
paraventricular thalamus; peri-fx, peri-fornical area; PFC, prefrontal cortex; Raphe,
Raphe nuclei; VLM, ventrolateral medulla; vSub, ventral subiculum; ZI, zona incerta.

Reprinted from “Stress-related synaptic plasticity in the hypothalamus,” by J. S. Bains, J.
I. Wamsteeker Cusulin, & W. Inoue. 2015. Nature Reviews. 16(7): 377–388. Copyright
(2015) Nature Reviews. Reprinted with permission.
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1.3.2.2

GABA

Just over half of all synaptic terminals in the PVN are GABAergic (Decavel & van den
Pol, 1992) and GABA terminals make the most synaptic contacts to CRH neurons
(Johnson, Bains, & Watts, 2018). Indeed, the HPA axis is normally constrained by
inhibition; a reduction in this tonic GABAergic drive (i.e., disinhibition) to CRH neurons
activates the HPA axis (Hewitt & Bains, 2006), whereas injection of GABA agonists
inhibit GC secretion following restraint stress (Cullinan, 1998). GABAergic projections
arise from a variety of areas including: the posterior regions of the BNST (Cullinan,
Herman, & Watson, 1993), dorsomedial hypothalamus (Cullinan et al., 1993), arcuate
nucleus (Baker & Herkenham, 1995; Canteras, Simerly, & Swanson, 1995), medial
preoptic nucleus (Viau & Meaney, 1996), anterior hypothalamus (Bali, Erdélyi, Szabó, &
Kovács, 2005), peri-fornical area, and from peri-PVN GABA neurons that project to
CRH neurons (Bowers, Cullinan, & Herman, 1998; Roland & Sawchenko, 1993). Many
of these GABAergic projections to the PVN are believed to serve as important relay sites
for the integration of stress signals from other brain areas (Herman, Mueller, &
Figueiredo, 2004). For example, the posterior BNST sends predominant GABAergic
projections to the PVN and integrates input from the central amygdala (Dong, Petrovich,
& Swanson, 2001; Redgate & Fahringer, 1973), which conveys information about
psychological stressors, as well as the medial amygdala (Cullinan et al., 1993), which is
activated by systemic stressors.

1.3.2.3

Glutamate

Glutamatergic transmission is the predominant excitatory input to the PVN and is a
crucial mediator of HPA axis activity (van den Pol, Wuarin, & Dudek, 1990). Injection of
glutamate into the PVN causes ACTH release (Darlington, Miyamoto, Keil, & Dallman,
1989), and injection of the glutamate receptor antagonist, kynurenate, into the PVN
reduces HPA axis responses to restraint stress (Ziegler & Herman, 2000). About half of
the terminals that appose CRH neurons are glutamatergic (Flak, Ostrander, Tasker, &
Herman, 2009) and these are mostly non-somatic (Johnson et al., 2018). Glutamatergic
synapses arise from a variety of areas including: periaqueductal gray, zona incerta,
subfasicular nucleus, parabrachial nucleus, raphe nuclei, nucleus of the solitary tract, and
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the ventrolateral medulla (Herman et al., 2003; Ziegler, Edwards, Ulrich-Lai, Herman, &
Cullinan, 2012). Many of these projections are thought to co-release other
neurotransmitters and peptides, such as noradrenaline, glucagon-like peptide,
neuropeptide Y, but not GABA (Ziegler, Cullinan, & Herman, 2002). Glutamate acts on
both pre- and postsynaptic ionotropic and metabotropic glutamate receptors. The
ionotropic component is thought to be primarily mediated by AMPA and NMDA
receptors; however, some studies have hinted towards a role for kainate action in the
PVN: Evanson, Van Hooren, and Herman (2009) showed that injection of a specific
kainate antagonist into the PVN increased release of ACTH and corticosterone and
increased c-Fos immunoreactivity in the PVN, indicating the paradoxical inhibitory roles
of kainite type glutamate receptors on PVN neurons’ excitability. Koenig and Cho (2005)
showed that kainate receptor mRNA was upregulated following hypoglycemia stress.
Interestingly, no electrophysiological evidence for kainate receptors in CRH neurons has
been found, leading to the conclusion that the majority of PVN glutamate signaling is
likely mediated by AMPA receptors.
Changes in glutamatergic synapses are likely important for HPA axis activation as well
as adaptation and plasticity following chronic stress (Evanson & Herman, 2015). It has
been shown that NMDA receptors undergo stress-induced plasticity following chronic
variable stress (Ziegler, Cullinan, & Herman, 2005), and acute immobilization (Bartanusz
et al., 1995). Also, the marker for presynaptic glutamate vesicles (vesicular glutamate
transporter 2; VGLUT2) is significantly increased following chronic variable stress,
suggesting increased glutamatergic innervation (Flak et al., 2009). Similarly, RRS
increased glutamatergic synaptic transmission to CRH neurons, as measured by an
increased frequency of excitatory activity. Further, our lab has recently shown that
chronic variable stress decreases glutamatergic synaptic multiplicity in CRH neurons,
thereby dampening synaptic gain (Salter, Sunstrum, Matovic, & Inoue, 2018). Clearly,
there is strong evidence that glutamate signaling plays an important role in the
modulation of the HPA axis, but precise changes in their functions require further
investigation.
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1.3.2.4

Catecholamine

A large portion of synaptic terminals in the PVN express markers for catecholamine
containing vesicles (tyrosine hydroxylase and dopamine beta dehydroxylase); however,
no adrenaline inputs have been discovered suggesting they likely secrete noradrenaline
(Johnson et al., 2018). Noradrenaline inputs to the PVN originate from brainstem nuclei,
specifically the ventral medulla, nucleus of the solitary tract, and locus coeruleus
(Swanson & Sawchenko, 1983). These inputs are known to activate the HPA axis
(Plotsky, Cunningham, & Widmaier, 1989) in response to both psychological (Kinzig et
al., 2003) and physiological stressors (Herman et al., 2003). It has been proposed that
noradrenergic terminals may co-release glutamate (Swanson & Sawchenko, 1983; UlrichLai & Herman, 2009).

1.3.2.5

Serotonin

Serotonin injection into the PVN increases ACTH and corticosterone secretion, and
therefore can activate the HPA axis (Feldman, Newman, & Weidenfeld, 2000; Pan &
Gilbert, 1992). Interestingly, there is only a small contribution of serotonergic fibers
innervating the PVN directly (Swanson & Sawchenko, 1983), which arise from the raphe
nuclei. There is a much higher density of serotonergic fibers in the area surrounding the
PVN, suggesting serotonin may act on GABAergic interneurons to CRH neurons, or
synapse on other excitatory inputs to CRH neurons, just outside of the parvocellular
PVN. However, it is still possible that these serotonergic fibers innervate distal dendrites
of CRH neurons that reach outside the borders of the parvocellular region. Although the
precise anatomy of this pathway is still elusive, there is strong evidence that the
serotonergic projection modulates HPA axis activity. Pharmacological lesions of the
serotonergic input (either by 5-HT antagonism in the PVN or raphe nuclei) result in a
blunted ACTH response to restraint stress and endotoxin-induced stress in rats
(Jørgensen, Knigge, Kjær, Vadsholt, & Warberg, 1998). It is possible that this is
mediated by direct action on CRH neurons, as electrophysiological data shows that 5HT2CR agonists cause CRH neuron depolarization and an increase in firing rate (Heisler
et al., 2007) and 5-HT1BR/5-HT6R activation resulted in c-Fos activation (Tung, Hardy,
Wheeler, & Belsham, 2012).

14

1.3.2.6

Dopamine

The PVN is innervated by dopaminergic projections from the zona incerta (Cheung,
Ballew, Moore, & Lookingland, 1998), which may co-release glutamate. Dopamine
receptor mRNA for D1, D2, D3, D4 and D5 have all been found in the PVN (Bitner et
al., 2006; Bouthenet et al., 1991; Fremeau et al., 1991; Gurevich & Joyce, 1999; Rivkees
& Lachowicz, 1997) and dopaminergic terminals are located in close proximity to CRH
neurons (Liposits & Paull, 1989) suggesting dopamine may regulate HPA axis responses.
Indeed, systemic administration of dopamine increases CRH mRNA production in the
PVN (Eaton, Cheung, Moore, & Lookingland, 1996) and activates the HPA axis
(Borowsky & Kuhn, 1992).

1.3.2.7

Summary

Although much work has been done to define the anatomical connections in the PVN, the
precise nature of specific projections and how they modulate subtypes of stressors is not
fully understood. It is likely that different neuromodulators work synergistically and
through heterosynaptic modulation to regulate other neurotransmitters within the PVN.

1.4 Habituation
A central characteristic of the stress response is that the experience of stress itself
changes subsequent responses. This has been shown extensively through the phenomenon
of stress habituation, i.e., the decrease in the magnitude of a response to a repeated
stressor (Grissom & Bhatnagar, 2009). For example, acute exposure to restraint in rats
produces a robust rise in plasma ACTH levels; however, repeated exposure to restraint
stress leads to attenuated production of ACTH with each subsequent exposure (Aguilera,
1994). Habituation has also been shown to occur in response to cold stress, novel
environment, water immersion, noise exposure, handling, and ethanol (Grissom &
Bhatnagar, 2009).
The concept of habituation was first characterized in a pioneering study by Thompson
and Spencer (1966), in which 9 criteria were outlined to determine whether a given
phenomenon represents habituation, which they defined as a “decrement as a result of
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repeated stimulation”. These criteria were revisited and confirmed in a more recent
review by a panel of experts in the field (Rankin et al., 2009) and specifically analyzed in
regards to stress habituation in the same issue (Grissom & Bhatnagar, 2009). Grissom
and Bhatnagar found that HPA axis habituation meets the criteria for habituation, and the
authors highlight some key features for HPA axis habituation. 1) The HPA axis
habituates to psychological (i.e., “perceived”) stressors more so than physiological (i.e.,
“real”) stressors. Although HPA axis activation occurs in response to both psychological
and physiological stressors, it is only psychological stressors that generate decrements in
stress responses with repeated exposure. The predicted adaptive value of this is simple;
the animal consistently mounts a response when it is physically (i.e., actually)
experiencing challenges, for example, injury, inflammation and starvation, but is able to
fine-tune the stress response to psychological (i.e., anticipated but not actually
happening) challenges based on the learned significance of a stressor. 2) Habituation is
stressor-specific. That is, habituation to one type of stressor (e.g., restraint in mice) does
not decrease subsequent responses to other stressors. This characteristic is one line of
evidence that distinguishes habituation from general GC negative feedback (a second is
that habituation is still evident in animals that lack GC negative feedback following
adrenalectomy (Jaferi & Bhatnagar, 2006)). In some cases, the HPA axis is actually
primed or sensitized for novel stressors after undergoing habituation to a repeated stressor
(Bhatnagar & Dallman, 1998).
Grissom and Bhatnagar (2009) also emphasized the importance of studying HPA axis
habituation and its mechanisms as it is closely linked to psychological disorders. It has
been suggested that depression and PTSD may involve a failure to habituate to chronic
stress. Despite the importance of this knowledge, remarkably little is known about the
neural mechanisms underlying habituation. Our lab has recently identified a possible
mechanism that could support habituation of the HPA axis. Inoue, Matovic, and Salter,
(2017) found that mice that have habituated to RRS show decreased intrinsic excitability
of CRH neurons. Specifically, CRH neurons fire fewer action potentials in response to
depolarizing current injections after chronic stress. A similar change in the intrinsic
excitability has been reported in rats after 3 days of repeated restraint (Kusek, Tokarski,
& Hess, 2013). As CRH neuron activation controls the activation of the HPA axis, this
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decreased input-output relationship is in line with habituation of the HPA axis, which
functionally manifests as a decreased HPA axis output in response to the same magnitude
of stress-relevant input.

1.5 Sensitization
It is important to note that the same chronic stress paradigms that lead to habituation to a
repeated (or familiar) stressor can cause enhanced (or normal) HPA responses to novel
(unfamiliar) stressors. In other words, a key characteristic of stress habituation is that it is
stressor specific. This conveys a survival advantage to habituation, as the animal can
conserve energy and not mount a full-blown response to a familiar, (learned to be)
unthreatening stressor but still maintain its ability to respond to a novel stressor that may
be life threatening. Sensitization of HPA axis responses have been found to occur in a
wide variety of stress paradigms. For example, exposure to chronic cold stress increases
HPA responses to restraint stress (Bhatnagar & Dallman, 1998); habituation to RRS
increases subsequent HPA responses to hypertonic saline challenge (Aguilera, 1994),
ether stress (Hauger, Lorang, Irwin, & Aguilera, 1990) and swim stress (Melia, Ryabinin,
Schroeder, Bloom, & Wilson, 1994); and chronic exposure to hypertonic saline elicits
sensitization to ether stress (Kiss & Aguilera, 1993). Despite the detailed characterization
of this phenomenon, the underlying neural mechanisms have not been determined. It has
been proposed that sensitization may involve plasticity across brain areas upstream of the
PVN. For example, in the prefrontal cortex of rats that were exposed to cold stress,
subsequent tail shock caused a greater increase in dopamine and noradrenaline release
when compared to naïve animals (Gresch, Sved, Zigmond, & Finlay, 1994). When
animals mount a sensitized response, it is likely that the neural circuits upstream of CRH
neurons are more active and synapses onto PVN CRH neurons are in higher activity state
than during normal and habituated responses. In line with this idea, Kusek, Tokarski, and
Hess (2013), found that RRS in rats increases the frequency of spontaneous excitatory
postsynaptic currents (sEPSCs) to CRH neurons, suggesting a possible correlate for
stress-induced sensitization. Overall, the underlying mechanisms for stress sensitization
have not been identified.
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1.6 Rationale, Hypothesis, Aims
1.6.1

Rationale

Animals can habituate at behavioural, hormonal, and neural levels to repeated mild stress;
however, the HPA axis maintains its ability to respond to novel or unfamiliar stressors
despite its habituated state. With respect to neuronal mechanisms, this dual modulation
predicts that there are two types of plasticity that allow animals to mount habituated and
sensitized responses. Despite years of work in the field, the neural correlates for these
opposing types of plasticity remain unknown. Our group recently found that RRS causes
a decrease in the intrinsic excitability of CRH neurons (Inoue et al., 2017) (Fig. 1.4),
which represents a neural correlate for HPA axis habituation. In line with this, c-Fos
immunoreactivity (a marker for recent neuronal activation) is reduced following RRS
(Fig. 1.5, unpublished), further supporting the idea that habituation occurs at the level of
CRH neurons. We have also obtained evidence that, in the same RRS model, a novel
stressor (cold swim) induced normal c-Fos activation (Fig. 1.5) consistent with the
stressor-specific nature of habituation. Importantly, this data indicates that the novel
stressor drove normal c-Fos activation (i.e., excitation) in CRH neurons despite their
decreased intrinsic excitability. Thus, our RRS paradigm provides a useful model to study
plasticity mechanisms for sensitization that overcome the decreased excitability of CRH
neurons and mount a normal (or possibly sensitized) stress response to a novel stressor.

1.6.2

Hypothesis

The activity of CRH neurons during stress is driven by the activity of their synaptic
inputs, and glutamate synapses are the major excitatory input to CRH neurons.
Hypothesis: RRS potentiates afferent glutamate synapses onto CRH neurons.

1.6.3

Aims

1. Characterize stress-induced glutamatergic synaptic plasticity in a mouse
model of RRS.
Experimental Approach
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To examine properties of glutamatergic synapses onto CRH neurons and their
plasticity following RRS, we obtained whole-cell patch clamp recordings from CRH
neurons and examined spontaneous excitatory postsynaptic currents (sEPSCs) in
brain slices from naïve and RRS mice.

Predictions
The potentiation of glutamate synapses manifests as a sensitization of these synapses
to stimuli that drive synaptic activity (mimicking the neural activity that occurs when
responding to a novel stressor). To this end, we stimulated the activity of glutamate
synapses by application of the cAMP activator, forskolin, to brain slices.

2. Identify the molecular mechanism by which stress alters glutamatergic
synaptic activity.
Experimental Approach
To identify the molecular mechanisms that underlie the RRS-induced potentiation of
glutamate synapses, we examined the detailed mechanisms by which forskolin
stimulates glutamate synapses and tested whether these mechanisms are altered after
RRS.

Predictions
We predict that molecular mechanisms mediating forskolin’s action on synaptic
stimulation are altered after RRS.
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Figure 1.4 CRH Neurons have decreased intrinsic excitability after RRS
(A) Representative current clamp traces illustrating a reduction in the CRH neuron spike
frequency after RRS (red) compared to naïve (blue). Firing elicited by a depolarizing step
from a hyperpolarized membrane potential. (B) Plot showing the spike frequency for a
given current injection. CRH neurons from RRS mice (red) show a lower spike frequency
for each current step compared to naïve (blue). Adapted from Inoue et al. (2017)
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Figure 1.5 CRH Neurons habituate to RRS but show normal activation to novel
stress.
(A) Schematic diagram of restraint stress tube (top) and stress timeline (bottom) for
repeated and novel stressors for c-Fos immunoreactivity, a marker for recent neuronal
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activation. RRS consisted of 21 days of 1 hour per day of restraint and a final episode of
restraint on the 22nd day before c-Fos analysis. In a second cohort of mice, 21 days of
RRS was followed by cold swim stress on the 22nd day before c-Fos analysis. (B)
Representative images of CRH neurons (red; top) and colocalization of CRH neurons and
c-Fos immunohistochemistry (white; bottom) for no stress (control), the first day of RRS
(Day 1 RRS), the final day of RRS-only condition (Day 22 RRS) and the RRS followed
by swim stress condition (Novel Stress). CRH neurons show habituation (decreased c-Fos
immunoreactivity) following 21 days of RRS but recover CRH activation in response to a
novel stressor. Adapted from Ichiyama and Inoue (unpublished).
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Figure 1.6 Hypothesis schematic diagram
Schematic diagram illustrating our hypothesis: RRS potentiates afferent glutamatergic
inputs to CRH neurons, which could overcome the decreased CRH neuron excitability
when responding to a novel stressor. (A) In stress-naïve animals, acute stressors activate
afferent synaptic inputs to CRH neurons, which increases their activity ultimately leading
to HPA axis activation. (B) Following RRS, CRH neurons have decreased intrinsic
excitability (a possible mechanism for habituation). We propose that a second form of
plasticity occurs in parallel, such that RRS potentiates the afferent glutamatergic inputs to
CRH neurons. This plasticity could support sensitization of the HPA axis.
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Chapter 2

2

Materials and Methods

2.1 Animals
All experimental procedures were approved by the University of Western Ontario Animal
Use Subcommittee and University Council on Animal Care in accordance with the
Canadian Council on Animal Care guidelines (2014-031). CRH reporter mice were bred
by crossing homozygous CRH-IRES-Cre (Stock 012704, Jackson Laboratory) with
homozygous ROSA26-tdTomato mice (Stock 007914, Jackson Laboratory) in the animal
facility of the University of Western Ontario. The heterozygous offspring, as
characterized in detail previously (Wamsteeker Cusulin et al., 2013), express tdTomato
fluorescence in all CRH producing cells, which allowed for visual identification of PVNCRH neurons during electrophysiology experiments (Fig. 2.1). All mice used were 8–14week-old males and were group-housed (2–4 per cage) under a 12H:12H light:dark cycle
(lights on at 07:00) with ad libitum access to food and water. Shoebox mouse cages were
supplied with mouse housing, paper nesting materials and wood chip bedding, and cages
were cleaned every 7 days.
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Figure 2.1 Visual identification of CRH neurons
In a slice electrophysiology preparation of the PVN, CRH neurons were identified by the
expression of tdTomato fluorescence (A; 10x magnification). (B) A patch-clamped CRH
neuron at 40x magnification under differential interference contrast (DIC; top) and
fluorescence (FLU; bottom).
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2.2 Repeated Restraint Stress Protocol
RRS consisted of daily 1-hour restraint (13:00–14:00 during the light phase) for 21
consecutive days. The restrainer was constructed from a ventilated 50 mL plastic tube
with an adjustable plunger to restrict forward/backward movement (Fig. 2.2). A hole was
cut in the lid to allow room for the tail when the lid was closed. In addition, plastic bars
were added to the bottom of the tube to prevent turning and rolling. Mice in restrainers
were placed in a large transparent plastic container (dimensions: 45cm length x 35cm
width x 20cm height). Following the session, mice were returned to their home cage and
all restrainers were sterilized using a 0.06% dilution of Virox (Diversey Inc.). Control
mice were kept in their home cage in the animal facility.
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Figure 2.2 Repeated restraint stress tube
The restrainer was constructed from a ventilated 50 mL plastic tube with an adjustable
plunger (plastic stick glued to button) to restrict forward/backward movement. Plastic
bars were glued to the bottom of the tube to prevent rolling.
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2.3 Slice Preparation
Stressed mice were sacrificed on the 22nd day following the 21-day RRS paradigm to
probe the lasting plasticity of CRH neurons. Mice were deeply anesthetized in a chamber
saturated with isoflurane and then decapitated. Brains were quickly removed and placed
in ice-cold slicing solution containing (in mM): 87 NaCl, 2.5 KCl, 0.5 CaCl2, 7 MgCl2, 25
NaHCO3, 25 D-glucose, 1.25 NaH2PO4 and 75 sucrose (osmolarity 315–320 mOsm)
saturated with 95% O2/5% CO2. Coronal sections (250 m thick) containing the PVN
were cut using a vibratome (VT-1200, Leica Biosystems). Slices were trimmed around
the PVN and transferred to artificial cerebrospinal fluid (aCSF) consisting of (in mM):
126 NaCl, 2.5 KCl, 26 NaHCO3, 2.5 CaCl2, 1.5 MgCl2, 1.25 NaH2PO4 and 10 D-glucose
(295–300 mOsm), saturated with 95% O2/5% CO2 and incubated at 35 C for 45 minutes.
Slices were subsequently maintained at room temperature. Experiments performed in
low-Ca2+ aCSF and zero-Ca2+ aCSF, were adjusted to (in mM): 0.5 CaCl2, 2.5 MgCl2 and
0 CaCl2, 4 MgCl2, respectively.

2.4 Electrophysiology
Slices were transferred to a recording chamber superfused with aCSF at a flow rate of
1.5–2.0 mL/min and maintained at 27–30 C. CRH neurons were visualized using a 40 ×
water-immersion lens on an upright microscope equipped with infrared differential
interference contrast optics (BX 51WI, Olympus) and epifluorescence optics. CRH
neuron identification was confirmed by the presence of tdTomato fluorescence and their
characteristic firing pattern in response to depolarizing current steps in current clamp
(Fig. 2.3; Luther & Tasker, 2000; Wamsteeker Cusulin et al., 2013). Borosilicate glass
recording pipettes (BF120-69-15, Sutter Instruments) were pulled in a Flaming/Brown
Micropipette Puller (P-1000, Sutter Instruments) with an open tip resistance between 3–5
M. Pipettes were filled with an internal solution containing (in mM): 116 K-gluconate,
8 KCl, 10 HEPES, 2 MgCl2, 4 K2ATP, 0.3 Na3GTP and 10 BAPTA-K4 (285–290 mOsm,
pH 7.2–7.4). Glutamatergic EPSCs were recorded by holding the CRH neuron soma at 68 mV in voltage clamp and isolated by adding picrotoxin (100 M) to the aCSF to block

28

GABAA receptors. Access resistance was monitored throughout the recording and cells
were discarded if the value exceeded 20 M.
In eEPSC experiments. Afferent CRH inputs were stimulated with a monopolar glass
electrode (1–3 μm open tip diameter) filled with aCSF and placed in the neuropil along
the third ventricle ventromedial to the PVN. A paired pulse protocol (0.2 Hz, 50 ms
apart) was used to investigate EPSC properties.
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Figure 2.3 Current clamp protocol for the identification of CRH neurons
(A) From a holding potential of -68 mV, a hyperpolarizing step of -20 pA was applied for
300 ms, followed by a 700 ms depolarizing pulse that increased by 10 pA increments
every sweep for a total of 10 sweeps. (B) Representative trace of parvocellular CRH
neuron firing pattern in response to a depolarizing current step.
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2.5 Pharmacology
For list of all reagents used see Table 2.1. Each drug was dissolved into stock solutions
and stored at -20 C, then diluted to their final concentration in the aCSF on the day of
the experiment. When DMSO or ethanol was used as a solvent, the final concentration of
solvent in the aCSF was ≤ 0.1%. All drugs were added to the aCSF and superfused into
the bath, unless otherwise specified.
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Reagent

Conc.
(μM)

Supplier

Cat #

Picrotoxin

100

Sigma

P1675

DNQX

10

Tocris

189

Forskolin

20

Sigma

F3917

TTX

0.5/1

T-550

CdCl2

10

Alomone
Labs
Sigma

202908

1,9-Dideoxyforskolin

20

Tocris

5034

Sp-cAMPS

100

IBMX

100

Biolog Life
Science
Cayman

C 01205
13347

ZD7288

15/70

Cayman

U0126

20

ESI 09
KT 5720

Action
GABAAR
antagonist
AMPA/kainate R
antagonist
Adenylyl cyclase
activator
VG Na+ blocker

Vehicle
DMSO
DMSO
Ethanol
H2O

Ca2+ channel
antagonist
Inactive forskolin
analog
cAMP analog

Ethanol

PDE inhibitor

Ethanol

15228

HCN antagonist

DMSO

Cayman

70970

ERK antagonist

DMSO

10

Tocris

4773

EPAC antagonist

DMSO

5

Tocris

1288

PKA antagonist

DMSO

CsCl

1–2 mM

Sigma

289329

NiCl2

500 μM
/1 mM
50

Sigma

203866

Tocris

3547
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Sigma

275875

Serotonin
hydrochloride
4-Aminopyridine

H2O

DMSO

non-specific HCN
antagonist
T-Type Ca2+
channel antagonist
5-HT R activator

H2O

Kv channel
antagonist

H2O

H2O
H2O

Table 2.1 Reagent Information
List of drugs used in all experiments. Concentrations are listed in μM, unless otherwise
specified.
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2.6 Data Collection, Analysis and Statistics
Whole cell patch clamp recordings were obtained using a Multiclamp 700B amplifier
(Molecular Devices, California, USA), low pass filtered at 1 kHz and digitized at a
sampling rate of 10 kHz using Digidata 1440A (Molecular Devices). Data was recorded
on a PC using pClamp 10.6 (Molecular Devices) and analyzed using MiniAnalysis
(Synaptosoft, Georgia, USA) and Clampfit (Molecular Devices). Statistical tests were
performed in GraphPad Prism 7 (GrapPad Software Inc, California, USA) and p < 0.05
was considered to be statistically significant. Two group comparisons were done using
paired t-tests, and two-way ANOVA’s were used for multiple group comparisons,
followed by Sidak’s test or Tukey’s test for post-hoc multiple comparisons. For sEPSC
analysis baseline data was taken at least 5 mins after breaking through into whole-cell
mode and a 0.5 or 1 min bin was used for analysis. Unless otherwise specified, drugs
were applied for 10 minutes and the last 0.5 or 1 min was used for analysis. To achieve
an accurate measure of the amplitude, individual sEPSCs were visually screened in
MiniAnalysis, and all overlapping events were removed for the calculation of the average
amplitude. Events below 5 pA were not included.
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Chapter 3

3

Results

One commonly used approach to estimate the function of synapses is to use patch-clamp
electrophysiology in acute brain slices and examine spontaneous (or miniature) synaptic
transmission, for example EPSCs mediated by ionotropic glutamate receptors. It is
generally accepted that the frequency of EPSCs reflects the combination of the following
two synaptic properties terminating onto a given postsynaptic neuron: 1) the number of
synapses (N) and 2) the (average) release probability of the of synapses (Pr). On the other
hand, the average amplitude reflects the postsynaptic sensitivity to release of a single
synaptic vesicle, typically postsynaptic receptor sensitivity to neurotransmitter (Q).
Accordingly, in order to probe synaptic plasticity resulting from behavioral manipulation,
the frequency and/or amplitude of sEPSCs recorded from one population of neurons are
compared between two conditions, for example under control condition versus after stress
exposure.
However, most of the studies using this approach only examine the “baseline” synaptic
activity in brain slices. This may not fully capture the properties of the synapses, as
synapses are likely to become more active (e.g., fire at high frequency) as a part of
physiologically relevant circuit activities. Therefore, for my MSc thesis, we first aimed to
develop an experimental strategy to study sEPSCs under stress-relevant states in brain
slices. One key intracellular signaling molecule that stimulates synaptic transmission is
3’,5’-cyclic adenosine monophosphate (cAMP), and cAMP mediates downstream
signaling of neuromodulators (e.g., 5HT receptor 4, 6 and 7, β-adrenergic receptors and
dopamine receptor D1) that drive stress-relevant neuronal activities. Thus, we used
forskolin, an adenylyl cyclase activator and recorded glutamatergic sEPSCs in the
presence of picrotoxin (GABAA receptor antagonist).

3.1 Forskolin drives glutamatergic synaptic transmission to
CRH neurons
As shown in Figure 3.1, 10 minutes of forskolin application (20 μM) robustly increased
the frequency of sEPSCs (Fig. 3.1 A, B; mean frequency: BL 9.22 ± 1.18 Hz vs. FSK
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29.45 ± 3.01 Hz; paired t test: p < 0.0001, n = 19). Forskolin also caused a moderate
increase in the mean amplitude of sEPSCs (Fig. 3.1 C; mean amplitude: BL 25.9 ± 1.16
pA vs. FSK 29.10 ± 1.17 pA, paired t test: p = 0.0022, n = 19) and a slight shift of the
amplitude distribution towards higher values (Fig. 3.1 D). To further characterize
forskolin’s effect on CRH neurons, we investigated forskolin-induced frequency increase
in Ca2+-free aCSF and in the presence of TTX to block Na2+-dependent action potentials.
Forskolin’s effect was not changed when normal aCSF (2.5 mM Ca2+) was replaced by
Ca2+-free aCSF (Fig. 3.1 E; frequency after forskolin: normal aCSF 29.45 ± 3.01 Hz (n =
19) vs. 0 M Ca2+ 32.17 ± 2.62 Hz (n = 7); two-way ANOVA: main effect of aCSF
condition: F (1, 24) = 0.4894, p = 0.4909). The frequency increase was decreased when
action potentials were blocked by the sodium (Na+) channel antagonist, TTX (frequency:
sEPSC 29.45 ± 3.01 Hz (n = 19) vs. mEPSC 19.22 ± 9.57 Hz (n = 10); two-way
ANOVA: main effect of aCSF condition: F (1, 27) = 6.111, p = 0.0200, interaction: : F
(1, 27) = 2.19, p = 0.1505; Sidak’s post-hoc test: FSK-sEPSC vs. FSK-mEPSC, p =
0.0113); however, mEPSC frequency was still increased by forskolin (two-way ANOVA:
main effect of forskolin: F (1, 27) = 88.65, p < 0.0001), suggesting that forskolin
increases both action potential-dependent and -independent EPSCs. To rule out the
possibility that forskolin acts by recruiting a new category of receptors, 6,7Dinitroquinoxaline-2,3-dione (DNQX; an AMPA and kainate receptor antagonist) was
applied after forskolin. Bath application of 10 μM DNQX abolished all synaptic activity
(Fig. 3.1 F), confirming that forskolin drives glutamatergic AMPA/kainate-mediated
sEPSCs.
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Figure 3.1 Forskolin increases glutamatergic synaptic activity
(A) Representative traces of sEPSC activity from before (grey) and 10 minutes after 20
μM forskolin application (orange) showing an increase in the frequency of sEPSCs. (B)
sEPSC frequency at baseline (BL; grey) and after 10 minutes of forskolin application
(FSK; orange; p < 0.0001). (C) Mean sEPSC amplitude (1-min bin) showed a slight
increase from baseline (BL; grey) to after 10 minutes of 20 μM forskolin application
(FSK; orange; p < 0.0022). (D) Mean amplitude distribution represented as fraction of
total events over 1 min bin for baseline (BL; grey) and after 10 minutes of 20 μM
forskolin application (FSK; orange, n = 19). Dotted line represents ± S.E.M. (E)
Forskolin-induced frequency increase was maintained in the absence of Ca2+ in the aCSF
(normal Ca2+ (blue) vs. 0 M Ca2+ (teal) at FSK: p = 0.4909). (F) Blocking AP-dependent
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events (grey; 1 μM TTX) decreased the forskolin-induced frequency increase (sEPSC vs.
mEPSC at FSK: p = 0.0113); however, forskolin still increased mEPSCs (BL-mEPSC vs.
FSK-mEPSC: p < 0.0001). Error bars represent ± S.E.M. (G) Representative trace
showing CRH neuron sEPSC activity in the presence of the GABAA receptor antagonist,
picrotoxin (100 μM; grey), was increased by forskolin (20 μM, orange), but all activity
was abolished by application of the AMPA/kainate receptor antagonist, DNQX (10 μM;
blue), confirming that forskolin drives glutamatergic synaptic activity. Each block
represents 3 mins of recording.
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3.2 RRS potentiates forskolin-induced frequency increase
in CRH neurons
After establishing forskolin as an efficient means to stimulate glutamatergic sEPSC
activity in PVN-CRH neurons, we tested whether habituation to chronic stress alters the
baseline and/or the capacity for forskolin to drive synaptic transmission (Fig. 3.2 A). The
baseline frequency was not statistically different between naïve and RRS (Sidak’s posthoc test: p = 0.1523 for BL-naïve vs. BL-RRS). In contrast, the frequency increase was
greater in RRS mice than naïve mice (Fig. 3.2 B, D; frequency at FSK: naïve 29.45 ±
3.01 Hz (n = 19) vs. RRS 48.34 ± 4.12 Hz (n = 16); two-way ANOVA: interaction: F (1,
33) = 10.77, p = 0.0024; Sidak’s post-hoc test: p <0.0001 for FSK-naïve vs. FSK-RRS),
which suggests that the stress-induced changes are related to forskolin’s mechanism of
action. Forskolin’s increase of the amplitude (Fig. 3.2 C, E; two-way ANOVA; main
effect of FSK: F (1, 33) = 16.56, p = 0.0003) was not altered by stress (main effect of
stress: p = 0.7696; interaction: p = 0.3797). To further examine the stress-induced
changes in glutamatergic synaptic activity, a separate experiment was performed in which
the K+ channel antagonist, 4-aminopyridine (4-AP), was used to stimulate synaptic
activity rather than forskolin. 4-AP blocks voltage-dependent K+ channels (Kv 1.1, 1.2,
1.3, 3.1; Coetzee et al., 1999), and causes a large increase in the frequency of sEPSCs. In
contrast to forskolin, 4-AP-induced frequency increase was not modified by stress (twoway ANOVA; main effect of FSK: F (1, 16) = 38.07, p < 0.0001, main effect of stress: p
= 0.6069, interaction: p = 0.3159, naïve: n = 9, RRS: n = 9), which further supports the
idea that stress is specifically changing the way forskolin drives synaptic activity. This
finding suggests that RRS is not causing an overall increase in the number of synapses,
but rather is altering forskolin’s mechanism of action.
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Figure 3.2 RRS potentiates forskolin-induced sEPSC frequency increase
CRH neurons from RRS animals show a greater increase in sEPSC frequency after
forskolin application. (A) Representative traces showing a CRH neuron from a naïve
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animal (top) and an RRS animal (bottom) at baseline (BL; grey) and after 10 mins of
forskolin application (FSK; blue and red for naïve and RRS, respectively). (B) RRS (red)
potentiated the forskolin-induced sEPSC frequency increase in CRH neurons compared
to naïve (blue; naïve vs. RRS at FSK: p < 0.0001). Baseline frequency was higher but not
significantly different after RRS (naïve vs. RRS at BL: p = 0.1523). (C) Mean sEPSC
amplitude over 1-minute bin at baseline (BL) and after 10 minutes of forskolin (FSK) in
naïve (blue) and RRS (red) mice. Forskolin slightly increased the amplitude in naïve and
RRS CRH neurons (p = 0.0003), but there was no difference between the two groups (p =
0.7696). (D) Individual cell data for sEPSC frequency for naïve and RRS at BL (grey)
and after 10 mins FSK (blue and red for naïve and RRS, respectively). (E) Individual cell
data for mean sEPSC amplitude for naïve and RRS at BL (grey) and after 10 mins FSK
(blue and red for naïve and RRS, respectively). (F) Probing sEPSC frequency with 4AP
(30 μM) did not reveal a difference between naïve and RRS (main effect of stress: p =
0.6069). Error bars represent ± S.E.M.
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3.3 Forskolin’s effects are dependent on adenylyl cyclase
and mimicked by cAMP
To further investigate how stress changes forskolin’s effect, we first had to determine
forskolin’s mechanism of action in CRH neurons from naïve mice. Forskolin is widely
known to stimulate PKA activity through an adenylyl cyclase-cAMP mechanism;
however, there are other downstream mechanisms reported in the literature (Fig. 3.3 A;
Emery & Eiden, 2012; Emery, Liu, Xu, Eiden, & Eiden, 2015; Huang & Hsu, 2005). To
pinpoint the mechanism through which forskolin increases sEPSC frequency in CRH
neurons, we targeted each pathway individually using pharmacology. Forskolin is a direct
activator of adenylyl cyclase, which catalyses the conversion of ATP into cAMP.
Therefore, if forskolin acts through the adenylyl cyclase-cAMP mechanism, cAMP alone
should mimic its effect. In line with this prediction, the drug Sp-cAMPS
triethylammonium salt (Sp-cAMP), a cAMP analog, increased the frequency of sEPSCs
(Fig. 3.3 C; BL 5.73 ± 1.37 Hz vs. Sp-cAMP 12.13 ± 2.37 Hz, paired t test: p = 0.0462, n
= 4). Endogenously, cAMP is broken down by phosphodiesterase (PDE), and
consequently, inhibiting PDE activity should increase endogenous levels of intracellular
cAMP. Indeed, we found that bath application of 1-Methyl-3-Isobutylxanthine (IBMX), a
PDE inhibitor, caused a large increase in the sEPSC frequency (Fig. 3.3 D; BL 9.86 ±
1.97 Hz vs. IBMX 22.77 ± 2.41 Hz, paired t test, p = 0.0033, n = 4). Taken together,
these data suggest that cAMP increases the frequency of sEPSCs in CRH neurons, which
indicates that forskolin is likely acting through adenylyl cyclase and cAMP to have its
effect on the frequency. While our data strongly supports an adenylyl cyclase-dependent
mechanism for forskolin’s effect, forskolin has been found to have nonspecific, adenylyl
cyclase-independent effects (Laurenza, Sutkowski, & Seamon, 1989), such as inhibition
of glucose transport in blood cells (Lavis, Lee, & Shenolikar, 1987), enhancement of
nicotinic receptor desensitization in muscle fibers (Middleton, Rubin, & Schuetze, 1988),
and modulation of voltage-gated K+ channels in neurons (Coombs & Thompson, 1987)
and T cells (Krause, Lee, & Deutsch, 1988). To rule out non-specific effects of forskolin,
we applied 1,9-dideoxyforskolin (DDFSK), an inactive forskolin analog, which mimics
the adenylyl cyclase-independent effects of forskolin. Bath application of DDFSK (20
μM) did not increase sEPSC frequency, but actually caused a slight decrease (Fig. 3.3 B;
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BL 6.22 ± 0.71 Hz vs. DDFSK 4.53 ± 0.55 Hz, paired t test: p = 0.0123, n = 9),
suggesting the increase in frequency seen with forskolin is mediated through an adenylyl
cyclase-dependent mechanism.
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Figure 3.3 Forskolin-induced frequency increase is dependent on adenylyl cyclase
and mimicked by cAMP
(A) Flow chart showing downstream targets of forskolin. Forskolin binds directly to
adenylyl cyclase but can have nonspecific effects. Adenylyl cyclase increases cAMP,
which can activate downstream pathways including: protein kinase A (PKA), exchange
factor regulated by cAMP (EPAC), extracellular regulated kinase (ERK) and
hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. (B) The inactive
forskolin-analog DDFSK (light purple; 20 μM), that mimics the adenylyl cyclaseindependent effects of forskolin, did not reproduce the forskolin-induced frequency
increase. (C) Sp-cAMP (pink; 100 μM), a cAMP analog, increased the frequency of CRH
neuron sEPSCs (p = 0.046). (D) Blocking phosphodiesterase (PDE)-dependent
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degradation of cAMP (and therefore increasing cAMP) with IBMX (dark purple; 100
μM) increased the sEPSC frequency (p = 0.003).
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3.4 Blocking HCN channels attenuates forskolin-induced
frequency increase
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are dually regulated
by membrane potential and by cAMP binding (He, Chen, Li, & Hu, 2014). The opening
of HCN channels is triggered by hyperpolarization of the cell membrane and causes a
depolarizing inward current, primarily composed of Na+. When cAMP is bound, HCN
channels (which normally open at membrane potentials more hyperpolarized than -50
mV) can open at a more depolarized membrane potential, which increases the proportion
of channels that are open at rest. Therefore, it is possible that the forskolin-induced
increase in cAMP is activating HCN channels, causing greater depolarization in
presynaptic terminals, and facilitating the release of synaptic vesicles. We next tested the
potential role of HCN channels by applying forskolin in the presence of the HCN channel
antagonist ZD7288 (ZD; Fig. 3.4 A). Bath application of ZD7288, at both 15 and 70 μM,
attenuated the sEPSC frequency increase by forskolin (Fig. 3.4 B; frequency: FSK 29.45
± 3.01 Hz (n = 19) vs. FSK+15 μM ZD 15.39 ± 2.07 Hz (n = 14) vs. FSK+70 μM ZD
16.19 ± 3.25 Hz (n = 12); two-way ANOVA: interaction: F (2, 41) = 6.54, p = 0.0034;
Tukey’s post-hoc test: FSK vs. FSK+15μM ZD: p < 0.0001, FSK vs. FSK+70μM ZD: p =
0.0002, FSK+15μM ZD vs. FSK+70μM ZD: p = 0.9937). ZD7288 application alone at
baseline did not change the frequency or amplitude (Tukey’s post-hoc test: BL vs.
BL+15μM ZD: p = 0.4106, BL vs. BL+70μM ZD: p = 0.5617, BL+15μM ZD vs.
BL+70μM ZD: p = 0.9971). To verify that ZD7288 effectively blocks HCN channels in
our preparation, we examined the characteristic HCN channel sag that is produced after
membrane hyperpolarization. As described earlier, hyperpolarization opens HCN
channels, which in turn generates an opposing depolarizing drive, and as a consequence
causes a sag in membrane hyperpolarization. We used a 30 pA hyperpolarizing step pulse
in current clamp for 5 seconds from a membrane potential of -40 mV to ensure HCN
channels were inactivated. CRH neurons have a small but readily detectable HCN sag
component (Fig. 3.4 C; black arrow): this sag was completely eliminated by bath
application of 15 μM ZD7288. As illustrated, blocking HCN channels prevented the
forskolin-induced frequency increase, suggesting forskolin may have its effect through
HCN channels.
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Figure 3.4 The HCN channel antagonist, ZD7288, attenuated the forskolin-induced
sEPSC frequency increase
(A) Representative traces showing that 70 μM ZD7288 application (grey) before
forskolin prevented the sEPSC frequency increase (green). (B) Application of forskolin in
the presence of 15 μM (yellow) and 70 μM (green) ZD7288 blocked the forskolininduced sEPSC frequency increase (FSK vs. FSK+15μM ZD: p = 0.0032, FSK vs.
FSK+70μM ZD: p = 0.0083). (C) Current clamp recordings from a representative CRH
neuron showing that the small HCN sag in CRH neurons (arrow) at baseline (black) was
blocked after bath application of 15 μM ZD (yellow). Current clamp protocol to reveal
the sag is shown at bottom; 30 pA hyperpolarizing step for 5 seconds from a holding
potential of -40 mV in the presence of 1 μM TTX. Error bars represent ± S.E.M.
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3.5 Forskolin’s mechanism is independent of PKA and
EPAC pathways but may involve the ERK pathway
While HCN channels clearly contribute to forskolin’s effect, the increase in frequency
was not completely abolished by blocking HCN channels, pointing to roles for additional
pathways. Next, we investigated three other pathways downstream of cAMP;
extracellular regulated kinase (ERK), exchange factor regulated by cAMP (EPAC) and
protein kinase A (PKA). Bath application of the ERK antagonist U0126 significantly
attenuated forskolin-induced frequency increase (Fig. 3.5 A; frequency: FSK 29.45 ±
3.01 Hz (n = 19) vs. FSK+U0126 12.88 ± 3.51 Hz (n = 6); two-way ANOVA:
interaction: F (1, 23) 5.739, p = 0.025; Sidak’s post-hoc test: BL vs. BL+U0126: p =
0.3190; FSK vs. FSK+U0126: p = 0.0008), suggesting that forskolin increases frequency
through the ERK pathway, in addition to HCN channels. In contrast, application of PKA
and EPAC antagonists (KT 5720 and ESI 09, respectively) did not weaken forskolin’s
effect (Fig. 3.5 B; frequency: FSK 29.45 ± 3.01 Hz (n = 19) vs. FSK+KT/ESI 23.97 ±
3.25 Hz (n = 4); two-way ANOVA: main effect of drug: p = 0.3662, interaction p =
0.6056), suggesting it is independent of these pathways.
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Figure 3.5 Forskolin’s mechanism is independent of PKA and EPAC but not ERK
pathways
(A) U0126, an ERK inhibitor (burgundy) attenuated the frequency increase (FSK vs.
FSK+U0126: p = 0.0008) compared to forskolin alone (blue). (B) Inhibiting PKA (KT
5720) and EPAC (ESI 09; purple) did not inhibit the increase in frequency compared to
forskolin alone (FSK vs. FSK+KT/ESI: p = 0.3662). Error bars represent ± S.E.M.
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3.6 Forskolin acts through presynaptic HCN channels
The classic interpretation based on quantal theory of neurotransmitter release (Del
Castillo & Katz, 1954; Redman, 1990; Stevens, 1993) indicates that a change in
frequency is due to a change presynaptic release. Therefore, forskolin likely increases
frequency through a presynaptic mechanism. To further investigate whether forskolin’s
mechanism is presynaptic, we recorded evoked EPSCs (eEPSCs) by stimulating the
afferent inputs to CRH neurons using an extracellular electrode placed in the neuropil
ventromedial to the postsynaptic neurons. Forskolin increased the eEPSC amplitude (Fig.
3.6 A–C; 135.4% of BL ± 12.36 %; paired t test: p = 0.0035, n = 12). In line with the
hypothesis that forskolin’s mechanism is presynaptic, this increase in eEPSC amplitude
was accompanied by a change in the coefficient of variation (1/CV2), which indicates
changes in Pr and N. Specifically, forskolin (Fig. 3.6 D, E; blue) increased 1/CV2 (BL vs.
FSK: p = 0.0236, n = 12), suggesting forskolin changes the probability of presynaptic
release. PPR was not significantly different (BL vs. FSK: p = 0.3952).
Our working hypothesis is that HCN channels mediate forskolin’s action on EPSCs. In
line with this idea, the forskolin-induced increase of eEPSC amplitude was completely
blocked by both 15 and 70 μM ZD7288 (Fig. 3.6 C; FSK 135.4% of BL ± 12.36 % (n =
12) vs. FSK+ZD 79.0% of BL ± 0.08 % (n = 15); two-way ANOVA: interaction: F (1,
25) = 14.03, p = 0.0009; Sidak’s post-hoc test: BL vs. BL+ZD: p = 0.9645, FSK vs.
FSK+ZD: p = 0.0067). Moreover, there was also a trend for ZD7288 to block the
forskolin-induced increase in 1/CV2 (Fig. 3.6 D; two-way ANOVA: interaction: F (1, 25)
= 4.11, p = 0.0534; Sidak’s post-hoc test: BL vs. BL+ZD: p = 0.9930, FSK vs. FSK+ZD:
p = 0.0134). As this data was not normally distributed (Shapiro-Wilk normality test: BL:
W = 0.6259, p = 0.0002; BL+ZD: W = 0.6426, p = 0.0001), 1/CV2 values were logtransformed. These data collectively suggest that forskolin acts through a presynaptic
mechanism and ZD7288 is able to block this mechanism.
If presynaptic HCN channels mediate forskolin’s effect, blocking HCN channels
specifically on the postsynaptic side should not change the effects of forskolin. We tested
this by applying the drug directly into the postsynaptic cell through the patch pipette.
ZD7288 is not cell permeable so when it is added to the intracellular solution and whole
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cell mode is established, ZD7288 will block only the postsynaptic, and not the
presynaptic, HCN channels. In contrast to bath application, ZD7288 in the pipette (ZDp)
at both 15 and 70 μM did not block forskolin-induced increase of the sEPSC frequency
(Fig. 3.6 F; two-way ANOVA: main effect of drug condition: F (3, 49) = 3.607, p =
0.0197; interaction: F (3, 49) = 3.85, p = 0.0150; Tukey’s post-hoc test: FSK vs.
FSK+15μM ZDp: p = 0.9971, FSK vs. FSK+70μM ZDp: p > 0.9999, FSK+15μM ZDbath
vs. FSK+15μM ZDp: p = 0.0036). As postsynaptic blockade of HCN channels was not
sufficient to block forskolin’s frequency increase, the HCN channels involved in
forskolin’s effect are likely presynaptic. This suggests a possible mechanism through
which forskolin increases sEPSC frequency: forskolin increases cAMP, which activates
presynaptic HCN channels and causes depolarization of the presynaptic terminals leading
to an increase in the release probability.
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Figure 3.6 Forskolin and ZD7288 act presynaptically
(A) Representative cell showing average paired-pulse eEPSC amplitude response at
baseline (black) was increased after 10 minutes of forskolin application (orange). (B)
eEPSC amplitude time-course expressed as a percent of the baseline (normalized to first
5 mins) amplitude. Forskolin application at time 0 (orange bar) increased eEPSC
amplitude. (C) Average eEPSC amplitude increased after forskolin (blue), but this
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increase was blocked by ZD7288 (yellow; FSK vs. FSK+ZD: p = 0.0067). (D) 1/CV2
increased after forskolin (blue), but this was blocked when ZD7288 (yellow) was present
(FSK vs. FSK+ZD: p = 0.0134). (E) PPR was not significantly different after forskolin
(blue) or in the presence of ZD7288 (yellow). (F) Forskolin-induced sEPSC frequency
was not blocked when ZD7288 was applied through the pipette at both 15 μM (dark
purple) and 70 μM (light purple), rather than bath applied (FSK+ZDbath vs. FSK+15μM
ZDp: p = 0.0036, FSK+ZDbath vs. FSK+70μM ZDp: p = 0.0079). Error bars represent ±
S.E.M.
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3.7 Blocking HCN channels eliminates the difference
between RRS and naïve animals
The above data revealed that presynaptic HCN channels at least partly mediate the effects
of forskolin on glutamate synapses in CRH neurons. Earlier, we also found that RRS
potentiates forskolin’s ability to drive synaptic transmission. Interestingly, chronic stress
has been found to upregulate HCN-mediated currents in the hippocampus (Kim, Brager,
& Johnston, 2017) and prefrontal cortex (Arnsten, 2011). In contrast, HCN-mediated
currents in the ventral tegmental area are decreased after chronic stress, which led to
increased anxiety and depressive behaviour (Zhong et al., 2018). Taken together, we
hypothesized that this stress-induced potentiation of synaptic transmission involves
changes in the presynaptic HCN channel mechanisms. If so, the blockade of HCN
channels should abolish stress-induced augmentation. In line with this prediction, we
found that application of ZD7288 prior to forskolin abolished the difference between
naïve and stressed mice. As seen in Figure 3.7 A, when ZD7288 was present, forskolin’s
effect was the same in naïve (yellow) and RRS (red; frequency: FSK+ZD-naïve 16.19 ±
3.25 Hz (n = 12) vs. FSK+ZD-RRS 14.41 ± 2.41 Hz (n = 6); two-way ANOVA: main
effect of stress: F (1, 16) = 0.05, p = 0.8179; main effect of forskolin: F (1, 16) = 24.42, p
= 0.0001; interaction: F (1, 16) = 0.2987, p < 0.5922). When HCN channels are blocked,
the stress-induced difference was eliminated, suggesting the initial difference may be due
to a change in HCN channel function after stress.
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Figure 3.7 Blocking HCN channels eliminates the difference between naïve and RRS
(A) In CRH neurons from RRS mice, the stress-induced potentiation of forskolin’s effect
was eliminated by ZD7288 (p = 0.8176). (B) Graph from Figure 3.2 for comparison,
showing the stress-induced difference in forskolin-induced increase of sEPSC frequency
without ZD7288. Error bars represent ± S.E.M.
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3.8 Cesium and nickel do not block forskolin’s effect
ZD7288 is generally considered a specific antagonist for HCN channels, and there are no
other inhibitors for HCN channels known to be more specific than ZD7288. However,
there are several studies reporting non-specific effects (Chen, 2004; Chevaleyre &
Castillo, 2002; Sánchez-Alonso, Halliwell, & Colino, 2008; Wu et al., 2012). As an
approach to validate the specificity of ZD7288, we used cesium (Cs+), which is known to
block HCN channels in addition to other ion channels including various K+ channels
(Adelman & French, 1978). Our prediction was that if ZD7288 reverses the effects of
forskolin by targeting HCN channels, Cs+ would produce similar effects by inhibiting the
same target. Unfortunately, Cs+ had non-specific actions that made it impossible to
analyze the effect of forskolin in our preparation. Specifically, Cs+ caused an increase in
the sEPSC frequency independent of forskolin, and forskolin-induced frequency increase
was not different in the presence of Cs+ (Fig. 3.8 A; frequency: FSK 29.45 ± 3.01 Hz (n =
19) vs. FSK+Cs+ 36.09 ± 5.42 Hz (n = 6), two-way ANOVA: main effect of condition: p
= 0.1335, interaction: p = 0.8560). Cs+ potently inhibits multiple K+ channels and, as a
consequence, increases the frequency of sEPSCs, which may have masked its antagonist
actions on HCN channels. Thus, the results from the Cs+ experiment are inconclusive.
As a complementary approach, we also examined potential (non-specific) targets of
ZD7288. One possible nonspecific effect of ZD7288 is the blockade of low-threshold (Ttype) Ca2+ channels (Sánchez-Alonso et al., 2008), which are expressed in the PVN. To
test this possibility, we used Nickel (Ni2+), a T-type Ca2+ channel antagonist, and applied
forskolin. Forskolin’s effect was not altered by Ni2+ application (Fig 3.8 B; frequency:
FSK 29.45 ± 3.01 Hz (n = 19) vs. FSK+Ni2+ 24.85 ± 7.22 (n = 6); two-way ANOVA:
interaction: p = 0.5693, main effect of Ni2+ condition: p = 0.8749). This result suggests
that ZD7288 was not acting on T-type Ca2+ channels to block the frequency increase.
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Figure 3.8 Cesium and nickel do not block sEPSC frequency increase
(A) Cesium (pink), the non-specific HCN antagonist did not block the frequency increase
by forskolin (p = 0.1335). (B) Ni2+ (teal), a T-type Ca2+ channel antagonist, did not block
forskolin-induced frequency increase (FSK vs. FSK+Ni2+: p = 0.5992).
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3.9 Serotonin mimics forskolin-induced frequency increase
Lastly, as forskolin is not endogenous, we were interested in identifying whether this
plasticity has physiological relevance with neuromodulators that act similarly to
forskolin. Forskolin activates the cAMP pathway, meaning it will likely mimic
neuromodulators that act on Gαs coupled G protein-coupled receptors (GPCRs). As
serotonin is known to innervate CRH neurons (Sawchenko, Swanson, Steinbusch, &
Verhofstad, 1983), we tested whether 5-HT could reproduce forskolin’s effects. We
found that bath application of 5-HT robustly increased sEPSC frequency in CRH neurons
(Fig. 3.9, A; BL 6.51 ± 1.70 Hz vs. 5-HT 19.04 ± 3.34 Hz, paired t test: p = 0.0269, n =
4), suggesting serotonin has the same effect as forskolin on CRH neurons. Therefore, as
forskolin causes a greater increase after stress, it is possible that serotonin inputs may
have a greater capacity to increase glutamatergic synaptic transmission after RRS.
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Figure 3.9 Serotonin increases sEPSC frequency in CRH neurons
(A) Bath application of serotonin (dark blue) increased the frequency of sEPSCs (p =
0.040).
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Chapter 4

4

Discussion

This study examined the plasticity of afferent glutamatergic inputs to CRH neurons in a
mouse model of RRS, in which mice habituate to the repeated stressor (restraint) while
maintaining a normal (or sensitized) response to a novel stressor. Our major finding is
that RRS potentiates glutamatergic synapses to CRH neurons, which manifested as an
increased response to cAMP stimulation by forskolin. Importantly, this stress-induced
synaptic potentiation, which became apparent when the synapses were active/stimulated,
was specific to the type of synaptic stimulation: forskolin (that elevates intracellular
cAMP), but not 4-AP (that increases action potential firing), revealed the increased
capacity for activity. This finding suggests that RRS animals may have a greater response
to neurotransmitters that activate cAMP pathways in the PVN. When we investigated this
mechanism further, we found that it was dependent on presynaptic HCN channels and
may have some involvement of the ERK pathway. Overall, this finding highlights a
possible mechanism which could support the ability of the HPA axis to mount a normal
(or sensitized) response to a novel stressor despite being habituated to chronic stress. Our
group has data showing that RRS decreases the intrinsic excitability of CRH neurons
(i.e., a decreased input-output relationship), and the present study suggests that
glutamatergic synapses onto CRH neurons are potentiated in the same RRS model. This
increased capacity for synaptic activity could overcome the decreased excitability by
increasing the synaptic drive to CRH neurons, suggesting it could serve as a mechanism
for sensitization to novel stress.

4.1 Forskolin as a means to drive synaptic activity
Forskolin causes a robust increase in glutamatergic synaptic activity in CRH neurons
resulting in an increase in the frequency of sEPSCs. We used forskolin, as a tool to study
the properties of glutamatergic synapses to CRH neurons under a “high activity” state
which would recapitulate stress-relevant physiological activity: neuromodulators that are
known to stimulate CRH neurons (noradrenaline, serotonin, dopamine) elevate
intracellular cAMP levels.
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Forskolin is a diterpene isolated from the Indian plant Coleus forskohlii that acts directly
on adenylyl cyclase to increase the levels of cAMP within cells (Seamon & Daly, 1981;
Seamon, Padgett, & Daly, 1981). The membrane bound enzyme, adenylyl cyclase,
catalyses the conversion of adenosine triphosphate (ATP) into 3’,5’-cyclic AMP (cAMP)
and pyrophosphate. Forskolin binds to all classes of mammalian adenylyl cyclase, with
the exception of IX, at a binding site that seems to be specific for forskolin, as no
endogenous molecules have been found to have the same mechanism (Hurley, 1999).
Hurley (1999) noted that the forskolin binding site is highly conserved across all classes
of adenylyl cyclase, despite there being no endogenous molecule that binds at the same
location. He suggested that this paradox may hint at the existence of an endogenous
“forskolin-like” small molecule that is able to activate adenylyl cyclase. As no such
molecule has been identified, forskolin has mainly been used as a proxy to study the
effects of GPCR pathways that activate adenylyl cyclase by the binding to the GαS
protein subunit. Forskolin has also been shown to have adenylyl cyclase-independent
binding to glucose transporters, voltage-gated K+ channels, ligand-gated ion channels and
P glycoproteins (Sunahara, Dessauer, & Gilman, 1996). Each of these effects are
mimicked by the inactive forskolin analog, DDFSK, which does not bind to adenylyl
cyclase (Laurenza et al., 1989). As DDFSK did not mimic the forskolin-induced effect on
sEPSC frequency in the present experiment, we concluded that the increase in frequency
by forskolin in CRH neurons is dependent on adenylyl cyclase. In line with this
conclusion we found that increasing cAMP, either by a cAMP analog or inhibition of
phosphodiesterases (PDEs), which break down cAMP, also increased sEPSC frequency
in CRH neurons. These data support the conclusion that forskolin is probing adenylyl
cyclase and its role in increasing intracellular cAMP and is therefore, an effective tool to
test the effect of GPCRs coupled to cAMP-stimulating GαS.
We also found that the stress-induced difference was specific to forskolin’s stimulation of
synaptic activity, rather than an overall increase in activity. As mentioned above, we used
a second approach to drive glutamatergic afferents, namely, stimulation of action
potential firing by blocking voltage-gated K+ channels with 4-AP. We have previously
shown that 4-AP increases sEPSC frequency in naïve mice (Salter et al., 2018); however,
in contrast to forskolin, there was no difference in 4-AP-induced frequency increase
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between RRS and naïve mice. This finding indicated that the stress-induced change we
observed was specific to the pathway forskolin was acting on and led us to investigate
forskolin’s mechanism further.
Interestingly, in vitro studies have shown that forskolin drives the release of CRH in a
cAMP-dependent manner (Hadley et al., 1996; Kumari, Cover, Poyser, & Buckingham,
1997). This was primarily attributed to forskolin-induced increases in CRH gene
transcription; however, our results suggest that there are potent acute effects of forskolin
on the excitatory synaptic inputs to CRH neurons, which could drive HPA axis activation
independent of the slower transcription pathways. This prompts an interesting study,
which suggests that the glutamatergic synaptic input to CRH neurons can actually trigger
downstream molecular machinery that ultimately results in the transcription of CRH
(Korosi et al., 2010). These findings highlight the importance of studying the acute
effects of driving cAMP on synaptic activity.

4.2 HCN channels
HCN channels are a unique class of ion channels that are activated by membrane
hyperpolarization and regulated by cyclic nucleotides (cAMP, cGMP). HCN channels
open at membrane potentials more negative to -50 mV, and cAMP facilitates their
activation by increasing the membrane potential at which they can open (He et al., 2014).
The opening of HCN channels causes an inward cationic current (Ih) that counteracts the
initial hyperpolarization. HCN channels are permeable to Na+, and to a lesser extent, K+
and Ca2+; however, as they open at hyperpolarized membrane potentials the Ih is
primarily composed of Na+. There are four subtypes of HCN channels (HCN1–4), and
each exhibit different activation kinetics and cAMP-sensitivity, with HCN2 and HCN4
being the most sensitive and HCN1 and HCN3 under weaker regulation (He et al., 2014).
HCN channels play an important role in regulating membrane potential and consequently
contribute to neuronal oscillations, dendritic integration and synaptic transmission in
various brain regions. The functional consequences of HCN channel activation depend
entirely on where in the brain and in the neuron, the channels are expressed. For example,
at the synaptic level, activation of HCN channels in presynaptic terminals has been found
to increase the amplitude of sEPSCs by increasing the Na+ gradient between the cytosol
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and synaptic vesicles, which is responsible for loading glutamate into synaptic vesicles
(Huang & Trussell, 2014). Alternatively, HCN channels expressed in distal dendrites can
decrease the membrane resistance and dampen dendritic integration, thereby decreasing
sEPSC amplitude (He et al., 2014). It has also been found that HCN channels can interact
with other ion channels to modify synaptic transmission. Given the diversity of effects on
neuronal activity, the modification and plasticity of HCN channels can have major
implications in diseases such as epilepsy, neuropathic pain, Parkinson’s disease, and
depression (He et al., 2014; Ku & Han, 2017; Lewis & Chetkovich, 2011).

4.3 Forskolin acts through presynaptic HCN channels
Here, we have found that presynaptic HCN channels are involved in forskolin-induced
sEPSC frequency increase in CRH neurons. Three lines of evidence support this
conclusion: 1) Forskolin increased the frequency and ZD7288 blocked the frequency
increase. The classic interpretation based on quantal theory of neurotransmitter release
(Del Castillo & Katz, 1954; Redman, 1990; Stevens, 1993) indicates that a change in
frequency is due to a change in presynaptic neurotransmitter release probability. 2)
Forskolin increased eEPSC amplitude which was paralleled by changes in synaptic
parameters indicative of presynaptic changes (i.e., an increase in 1/CV2). Similar to
sEPSC changes, ZD7288 blocked the forskolin-induced amplitude increase as well as the
accompanying changes in 1/CV2. 3) ZD7288 application through the postsynaptic pipette
did not block forskolin’s effect. ZD7288 blocks HCN channels through the interaction
with residues in the channel pore (Shin, Rothberg, & Yellen, 2001), and as ZD7288 does
not easily cross the cell membrane (Stieber, Stöckl, Herrmann, Hassfurth, & Hofmann,
2005), it is possible to determine the location of the HCN channels by applying the drug
in the postsynaptic pipette (Horwitz, Risner-Janiczek, & Holt, 2014). ZD7288 only
prevented the frequency increase when it was bath applied and, therefore, blocking
presynaptic HCN channels. This suggests that the HCN channels responsible for
forskolin’s effect are presynaptic.
While our data strongly support our conclusion that presynaptic HCN channels mediate
forskolin’s action on sEPSC frequency, HCN channels are also expressed in a portion of
postsynaptic CRH neurons and may be important for other cell properties, such as the
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postsynaptic excitability and/or synaptic integration. Whole-brain HCN in situ
hybridization studies have identified high levels of HCN3 mRNA in the PVN, moderate
levels of HCN 1 and HCN4 and low levels of HCN2 (Monteggia, Eisch, Tang,
Kaczmarek, & Nestler, 2000). In contrast, single-cell RT-mPCR data shows that HCN1,
HCN2, and HCN3 were present in cells that were electrophysiologically identified as
parvocellular neurons (Qiu et al., 2005). Egli, Berger, & Imboden (2002) found that the Ih
exists in 59 % of electrophysiologically identified parvocellular PVN neurons, although
they did not distinguish between autonomic and neurosecretory subtypes. Using our
CRH-reporter mouse line, we were able to confirm that a portion (approximately 50%) of
parvocellular CRH-secreting neurons possess HCN channels by the identification of the
characteristic “voltage sag” (the slight depolarization in response to hyperpolarization in
current clamp; see Fig. 3.4 C). Importantly, the postsynaptic sag was blocked when
ZD7288 was applied through the pipette, confirming that the drug was blocking
postsynaptic HCN channels. Despite the postsynaptic HCN blockade, ZD7288
application through the pipette was not sufficient to block forskolin’s effect, suggesting
the HCN channels involved in forskolin-induced frequency increase are located on the
presynaptic terminals.
We propose that forskolin increases cAMP in afferent presynaptic terminals, which binds
to and opens HCN channels. Presynaptic HCN channels have been found to facilitate
synaptic transmission in two ways: 1) HCN channels depolarize synaptic terminals,
thereby decreasing the threshold for action-potential generation and increasing the
frequency of spontaneous action potential-dependent EPSCs, as has been shown in the
cerebellum, basolateral amygdala and CA1 region of the hippocampus (He et al., 2014;
Park et al., 2011; Southan, Morris, Stephens, & Robertson, 2000); 2) HCN channels can
be located near release machinery and cause a depolarization that activates high-threshold
voltage-gated P/Q-type Ca2+ channels thereby facilitating neurotransmitter release. This
action potential-independent form of HCN-induced facilitation has been found in the
dentate gyrus and Calyx of Held (Aponte, Lien, Reisinger, & Jonas, 2006; Awatramani,
Price, & Trussell, 2005). Further experiments are needed to determine the exact
mechanism through which HCN channels increase sEPSC frequency in CRH neurons,
but it is possible that both mechanisms are at work, as forskolin drives both action
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potential-dependent and -independent EPSCs. A future direction for this project is to
investigate forskolin’s effect in the presence of ZD7288 and TTX to block action
potential-dependent release.
Experiments in other systems have revealed similar roles for HCN channels in
presynaptic transmission. In substantia gelintinosa neurons, ZD7288 decreased sEPSC
and mEPSC frequency through a presynaptic mechanism and partially inhibited the
forskolin-induced increase in mEPSC frequency for excitatory but not inhibitory
transmission (Peng et al., 2017). It was also reported that HCN channels underlie a form
of LTP that requires a presynaptic cAMP/PKA-dependent mechanism in hippocampal
mossy fibers (Mellor, Nicoll, & Schmitz, 2002). This finding was quickly contradicted by
Chevaleyre & Castillo (2002), who showed that presynaptic HCN channels are not
involved in mossy-fiber LTP. The role of HCN channels in presynaptic forms of LTP has
yet to be determined, but this controversy has prompted investigation into the specificity
of HCN channel blockers.

4.4 ZD7288 specificity
Our conclusion that forskolin acts through HCN channels to increase the frequency is
based on the pharmacology and specificity of the antagonist ZD7288. Although ZD7288
is generally considered to be a specific antagonist for HCN channels, some non-specific
effects have been reported at higher concentrations. ZD7288 has been shown to block Ttype Ca2+ channels in the hippocampus with an IC50 of 40 μM (Sánchez-Alonso et al.,
2008), suggesting a small portion of these channels could be blocked at the low
concentration we used (15 μM) and possibly a significant amount at the higher
concentration (70 μM). To rule out the possibility that ZD7288 was blocking sEPSC
frequency through T-type Ca2+ channels, we applied forskolin in the presence of Ni2+
(500 μM–1 mM), which is known to specifically block T-type Ca2+ channels (Mlinar &
Enyeart, 1993; Todorovic & Lingle, 1998). Unlike ZD7288, Ni2+ had no effect on the
forskolin-induced frequency increase, suggesting ZD7288 was not acting through T-type
Ca2+ channels. In another study, ZD7288 was found to block Na+ channels in dentate
granule cells and HEK cells transfected with Nav1.4 (Wu et al., 2012). Blockade of Na+
channels would be expected to decrease sEPSC frequency; however, this is unlikely as
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Nav1.4 channels are not expressed in the PVN (Feetham, O’Brien, & Barrett-Jolley,
2018), and this effect of ZD7288 has not been reproduced in any other brain area or on
any other Na+ channel subtypes.
HCN channels are known to be sensitive to Cs+ in the extracellular medium, which
blocks HCN channels in the low mM range (1–6 mM; Southan, Morris, Stephens, &
Robertson, 2000). We attempted to use Cs+ to verify that forskolin acts through HCN
channels. Unfortunately, this experiment was inconclusive as Cs+ had non-specific effects
that increased the frequency of sEPSC and made it impossible to analyse forskolin’s
effect. In addition to blocking HCN channels, Cs+ potently blocks various types of
voltage-dependent K+ channels. In slice patch clamp recordings from CRH neurons, we
have shown that blocking K+ channels (as seen in the 4AP experiment and Salter et al.
(2018)) causes a robust increase in the sEPSC frequency. This action of Cs+ would mask
any effect of blocking HCN channels (which is expected to decrease sEPSC frequency).
For this reason, we cannot conclude from our data whether cesium’s block of HCN
channels affected forskolin’s action. Recently, Ivabraine has been suggested to be a more
useful HCN channel blocker, as it lacks effects on Na+, Ca2+ and K+ currents; however, it
has been reported that it is selective for HCN4 (Romanelli et al., 2016), which may have
low expression in the PVN (Qiu et al., 2005). Regardless, further experiments are needed
to test the selectivity of ZD7288 on HCN channels in CRH neurons.

4.5 Modulation of HCN channels by cAMP via GPCRs
It has been proposed based on the structure and anatomy of the PVN, that CRH neurons
are under heterosynaptic modulation; the phenomenon where one transmitter system
affects neighbouring systems (Bains, Wamsteeker Cusulin, & Inoue, 2015). This is based
on the low spine density of CRH dendrites and the mixed organization of
neurotransmitter contacts. For example, innervation of the PVN by noradrenaline
afferents can modulate GABAergic synaptic transmission to CRH neurons (Inoue et al.,
2013). This is even more promising with the knowledge that glutamate and GABA
synapses in the PVN co-release other neurotransmitters and peptides (Johnson et al.,
2018). This model fits well with our data as we have shown that activation of adenylyl
cyclase positively modulates glutamatergic transmission to CRH neurons. Therefore, it is
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possible that neurotransmitters that activate adenylyl cyclase (namely through stimulatory
GPCRs) are capable of augmenting glutamatergic synapses to CRH neurons. This is
supported by our finding that serotonin application in the PVN increased the frequency of
glutamatergic sEPSCs in CRH neurons. This type of mechanism has been shown in the
crayfish neuromuscular junction, where cAMP modulation of presynaptic HCN channels
by serotonin enhanced synaptic transmission (Beaumont & Zucker, 2000). It is also
possible that intra-PVN microcircuits are modulated by HCN channels expressed in
parvocellular PVN neurons. Electrophysiologically identified parvocellular neurons
showed a positive shift in the Ih in response to angiotensin (which is GPCR-coupled)
application (Egli et al., 2002) and parvocellular PVN neurons have been shown to
organize into intra-PVN circuits that modulate HPA axis activation (Jiang,
Rajamanickam, & Justice, 2018). In contrast, α2-adrenoreceptor agonists suppressed Ih in
parvocellular neurons, which was weakly modulated by cAMP (Shirasaka, Ph, Kannan,
& Takasaki, 2007), suggesting cAMP levels can bidirectionally influence HCN channels
and their effect on synaptic transmission.

4.6 ERK pathway
Although forskolin is commonly known to activate PKA and/or EPAC pathways, our
data suggests that forskolin’s effect on the frequency was independent of these common
pathways. A third target downstream of cAMP is the extra cellular regulated kinase
pathway (ERK; Emery & Eiden, 2012). The ERK pathway (also known as the MAPK
pathway) is a kinase cascade pathway that activates transcription of a variety of genes but
has also been shown to increase neurotransmitter release through its interaction with
synapsin (Riganti et al., 2016; Vara, Onofri, Benfenati, Sassoè-Pognetto, & Giustetto,
2009). Due to its role in presynaptic release, we cannot rule out the possibility that
blocking ERK decreased sEPSC frequency independently of forskolin. Considering the
fact that the ERK inhibitor U0126 decreased the baseline frequency before application of
forskolin, ERK signaling may indeed be required for presynaptic release rather than
upregulated by forskolin. At this time, more experiments are needed to investigate the
role of ERK in forskolin-induced frequency increase.

66

4.7 Sensitization at the level of CRH afferents
Our mouse model of chronic stress, RRS, causes habituation at the level of the CRH
neurons as shown by a reduction in c-Fos immunoreactivity and as a decrease in the
intrinsic excitability. Importantly, following RRS, subsequent exposure to novel stress
(e.g., cold swim) recovers c-Fos immunoreactivity despite the CRH neurons’ habituation.
This points to two distinct forms of plasticity, that decrease sensitivity to homotypic
stressors while also maintaining a normal response to novel stressors. In the present
study, we found that CRH neurons from mice exposed to the same RRS paradigm, show
a greater capacity for synaptic activity at the level of the CRH afferents. This finding is
similar to Kusek and colleagues (2013)’s finding that sEPSC frequency was greater after
RRS. One difference was that the previous study revealed a stress-induced difference at
baseline, whereas the present study only showed a trend towards a baseline frequency
increase after RRS. As the activity of afferent inputs to CRH neurons determines their
activity (and subsequent HPA axis activation), this increased capacity may compensate
for habituation by increasing the response to incoming stress signals. Specifically, we
found that the stress-induced synaptic change was only evident when synapses were
driven (by forskolin) to a high level of activity and not at the baseline. This could suggest
that exposure to a novel stressor, which would elicit high afferent stress activity to the
PVN, would cause a greater response in CRH neurons after RRS. This finding supported
our hypothesis that stress sensitization could manifest as an upregulation of neural circuit
upstream of CRH neurons. However, further experiments are needed to show a causal
link between this plasticity and hormonal or behavioural sensitization of HPA axis
responses. Interestingly, our effect was not found to be an overall increase in synaptic
activity (as shown by 4-AP experiments), but rather a difference in the response to
cAMP-dependent activity, which may hint as to how a novel stressor is “coded” at the
level of the PVN. In support of this theory, Gaillet, Lachuer, Malaval, Assenmacher, &
Szafarczyk (1991) propose that specific neurotransmitter pathways (e.g., noradrenaline)
represent specific types of stressors (Pacak & Palkovitis, 2001).
Our data revealed that presynaptic HCN channels partially mediate the effects of
forskolin on glutamatergic transmission to CRH neurons. Interestingly, HCN channels
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have been found to undergo plasticity in response to chronic stress in other brain areas.
Chronic stress increases HCN-mediated currents in the hippocampus and prefrontal
cortex (Arnsten, 2011; Kim et al., 2017) but decreases HCN-mediated currents in the
ventral tegmental area (Zhong et al., 2018), which was found to increase anxiety and
depression behaviour. In line with these studies our data suggest that chronic stress
causes HCN channel plasticity. Specifically, we propose that RRS upregulates the Ih,
thereby increasing the capacity for forskolin-induced sEPSC increase through HCN
channels. Future studies should attempt to pinpoint the nature of the HCN channel
plasticity. Genetic approaches that modulate HCN channel expression can also be used to
determine to what extent HCN channels modulate behavioural responses to stress in vivo.
We believe the mechanism identified in the present study supports the ability of the HPA
axis to respond normally (or in a sensitized manner) to a novel stressor despite being
habituated to chronic stress.

4.8 Conclusion
This study identified a form of chronic stress-induced synaptic plasticity that could
support sensitization of the HPA axis. We found that RRS potentiated glutamatergic
afferents to CRH neurons, which manifests as a sensitization of these synapses to
stimulation by the cAMP activator, forskolin. As our recent work showed that the
intrinsic excitability of CRH neurons decreases after RRS (Inoue et al., 2017), the
potentiated afferent activity may serve to overcome the decreased CRH neuron
excitability when responding to novel stress. Specifically, we found that the response to
the forskolin-induced increase in sEPSC frequency was greater after RRS, and this RRSinduced synaptic potentiation was lost in the presence of the HCN channel antagonist
ZD7288. Our data also indicate that the HCN channels targeted by ZD7288 are located
on presynaptic terminals and facilitate the release of glutamate upon cAMP signaling.
The ability of the HPA axis to undergo experience-dependent activity and habituate to
chronic stress is a key mechanism that allows animals to conserve energy and prevent the
detrimental effects of chronic glucocorticoid exposure. However, it is not adaptive to
have a “downregulated” stress response if a novel stressor is encountered; therefore, a
mechanism that allows the stress response to overcome habituation and respond to

68

unfamiliar stressors is vital to the survival of the animal. These data identify a possible
mechanism and further our understanding of this important form of plasticity.
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